Pregnancy Care during the COVID-19 Pandemic in Germany: A Public Health Lens.
Antonia LeißeJulia DötzerAlice RuhnauLeona AschentrupFlorian FischerKamil J WronaPublished in: International journal of environmental research and public health (2023)
The COVID-19 pandemic has led to various challenges in German health care, including pregnancy care. This paper aims to provide an overview of the pandemic-related challenges faced by pregnant women, new mothers, and their families in maternal and newborn care. A literature review was performed by including international literature as well as recommendations of institutions and official stakeholders. These challenges refer to restrictions at all stages of pregnancy, including wearing masks during labour, limitations of a companion of choice during birth, and restrictions of unvaccinated women from attending, e.g., antenatal classes. Compared with the general population, COVID-19 vaccination of pregnant women was recommended later, as pregnant women were initially excluded from clinical trials. Women who gave birth during the COVID-19 pandemic also reported mental health issues. The findings stress the importance of the inclusion of pregnant women in clinical trials. This might also help to overcome vaccine hesitancy among pregnant women and women seeking family planning. Taking the COVID-19 pandemic as an example, one must weigh the changes and restrictions associated with the potential disadvantages for mothers, newborns, and their families in pregnancy care against the measures to control the pandemic.
Keyphrases
- pregnancy outcomes
- pregnant women
- healthcare
- clinical trial
- coronavirus disease
- sars cov
- mental health
- palliative care
- public health
- quality improvement
- affordable care act
- systematic review
- preterm birth
- polycystic ovary syndrome
- type diabetes
- adipose tissue
- physical activity
- gestational age
- randomized controlled trial
- risk assessment
- social media
- body mass index
- climate change
- health information
- respiratory syndrome coronavirus
- skeletal muscle
- open label
- global health